CRIS

Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1

Browse

Search Results

Now showing 1 - 7 of 7
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Connexin46 in the nucleus of cancer cells: a possible role as transcription modulator
    (Springer Science and Business Media LLC, 2025-03-27)
    Ainoa Fernández-Olivares
    ;
    Viviana P Orellana
    ;
    Jesús Llanquinao
    ;
    ;
    Pablo Pérez-Moreno
    Scopus© Citations 1  10
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Biphasic effect of linoleic acid on connexin 46 hemichannels
    (2011) ;
    Flavio Evangelista-Martínez
    ;
    Carmen G. León-Paravic
    ;
    Guillermo A. Altenberg
    ;
    Luis Reuss
      5Scopus© Citations 28
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Connexins in Cancer, the Possible Role of Connexin46 as a Cancer Stem Cell-Determining Protein
    (2023)
    Isidora M. León-Fuentes
    ;
    María G. Salgado-Gil
    ;
    María S. Novoa
    ;
    <jats:p>Cancer is a widespread and incurable disease caused by genetic mutations, leading to uncontrolled cell proliferation and metastasis. Connexins (Cx) are transmembrane proteins that facilitate intercellular communication via hemichannels and gap junction channels. Among them, Cx46 is found mostly in the eye lens. However, in pathological conditions, Cx46 has been observed in various types of cancers, such as glioblastoma, melanoma, and breast cancer. It has been demonstrated that elevated Cx46 levels in breast cancer contribute to cellular resistance to hypoxia, and it is an enhancer of cancer aggressiveness supporting a pro-tumoral role. Accordingly, Cx46 is associated with an increase in cancer stem cell phenotype. These cells display radio- and chemoresistance, high proliferative abilities, self-renewal, and differentiation capacities. This review aims to consolidate the knowledge of the relationship between Cx46, its role in forming hemichannels and gap junctions, and its connection with cancer and cancer stem cells.</jats:p>
    Scopus© Citations 3  2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Data-driven historical characterization of epilepsy-associated genes
    (2023)
    Marie Macnee
    ;
    ;
    Javier A. López-Rivera
    ;
    Alina Ivaniuk
    ;
    Patrick May
      1  1Scopus© Citations 28
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Conserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes
    (2022)
    Tobias Brünger
    ;
    ;
    Ludovica Montanucci
    ;
    Michael Nothnagel
    ;
    Rikke S Møller
    <jats:title>Abstract</jats:title> <jats:p>Clinically identified genetic variants in ion channels can be benign or cause disease by increasing or decreasing the protein function. As a consequence, therapeutic decision-making is challenging without molecular testing of each variant. Our biophysical knowledge of ion-channel structures and function is just emerging, and it is currently not well understood which amino acid residues cause disease when mutated.</jats:p> <jats:p>We sought to systematically identify biological properties associated with variant pathogenicity across all major voltage and ligand-gated ion-channel families. We collected and curated 3049 pathogenic variants from hundreds of neurodevelopmental and other disorders and 12 546 population variants for 30 ion channel or channel subunits for which a high-quality protein structure was available. Using a wide range of bioinformatics approaches, we computed 163 structural features and tested them for pathogenic variant enrichment. We developed a novel 3D spatial distance scoring approach that enables comparisons of pathogenic and population variant distribution across protein structures.</jats:p> <jats:p>We discovered and independently replicated that several pore residue properties and proximity to the pore axis were most significantly enriched for pathogenic variants compared to population variants. Using our 3D scoring approach, we showed that the strongest pathogenic variant enrichment was observed for pore-lining residues and alpha-helix residues within 5Å distance from the pore axis centre and not involved in gating. Within the subset of residues located at the pore, the hydrophobicity of the pore was the feature most strongly associated with variant pathogenicity. We also found an association between the identified properties and both clinical phenotypes and functional in vitro assays for voltage-gated sodium channels (SCN1A, SCN2A, SCN8A) and N-methyl-D-aspartate receptor (GRIN1, GRIN2A, GRIN2B) encoding genes. In an independent expert-curated dataset of 1422 neurodevelopmental disorder pathogenic patient variants and 679 electrophysiological experiments, we show that pore axis distance is associated with seizure age of onset and cognitive performance as well as differential gain versus loss-of-channel function.</jats:p> <jats:p>In summary, we identified biological properties associated with ion-channel malfunction and show that these are correlated with in vitro functional readouts and clinical phenotypes in patients with neurodevelopmental disorders. Our results suggest that clinical decision support algorithms that predict variant pathogenicity and function are feasible in the future.</jats:p>
      1Scopus© Citations 13  6
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Analysing an allelic series of rare missense variants of <i>CACNA1I</i> in a Swedish schizophrenia cohort
    (2021)
    David Baez-Nieto
    ;
    Andrew Allen
    ;
    Seth Akers-Campbell
    ;
    Lingling Yang
    ;
    Nikita Budnik
    <jats:title>Abstract</jats:title> <jats:p>CACNA1I is implicated in the susceptibility to schizophrenia by large-scale genetic association studies of single nucleotide polymorphisms. However, the channelopathy of CACNA1I in schizophrenia is unknown. CACNA1I encodes CaV3.3, a neuronal voltage-gated calcium channel that underlies a subtype of T-type current that is important for neuronal excitability in the thalamic reticular nucleus and other regions of the brain. Here, we present an extensive functional characterization of 57 naturally occurring rare and common missense variants of CACNA1I derived from a Swedish schizophrenia cohort of more than 10 000 individuals. Our analysis of this allelic series of coding CACNA1I variants revealed that reduced CaV3.3 channel current density was the dominant phenotype associated with rare CACNA1I coding alleles derived from control subjects, whereas rare CACNA1I alleles from schizophrenia patients encoded CaV3.3 channels with altered responses to voltages. CACNA1I variants associated with altered current density primarily impact the ionic channel pore and those associated with altered responses to voltage impact the voltage-sensing domain. CaV3.3 variants associated with altered voltage dependence of the CaV3.3 channel and those associated with peak current density deficits were significantly segregated across affected and unaffected groups (Fisher’s exact test, P = 0.034). Our results, together with recent data from the SCHEMA (Schizophrenia Exome Sequencing Meta-Analysis) cohort, suggest that reduced CaV3.3 function may protect against schizophrenia risk in rare cases. We subsequently modelled the effect of the biophysical properties of CaV3.3 channel variants on thalamic reticular nucleus excitability and found that compared with common variants, ultrarare CaV3.3-coding variants derived from control subjects significantly decreased thalamic reticular nucleus excitability (P = 0.011). When all rare variants were analysed, there was a non-significant trend between variants that reduced thalamic reticular nucleus excitability and variants that either had no effect or increased thalamic reticular nucleus excitability across disease status. Taken together, the results of our functional analysis of an allelic series of &amp;gt;50 CACNA1I variants in a schizophrenia cohort reveal that loss of function of CaV3.3 is a molecular phenotype associated with reduced disease risk burden, and our approach may serve as a template strategy for channelopathies in polygenic disorders.</jats:p>
    Scopus© Citations 22  1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Gap-junctional channel and hemichannel activity of two recently identified connexin 26 mutants associated with deafness
    (2016)
    Viviana Dalamon
    ;
    Mariana C. Fiori
    ;
    Vania A. Figueroa
    ;
    Carolina A. Oliva
    ;
    Rodrigo del Rio
      12Scopus© Citations 15